Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4, 2023. …
Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com. Reminder, we can’t offer personal investing advice. We will only consider more general questions about the …
The Club’s top 10 things to watch Friday, July 21 1. Stocks are steady ahead of the Nasdaq 100’s special rebalance, but be on guard for volatility as the index …
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in …
Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company‘s first quarterly report since it spun out from Johnson & Johnson two months ago. …
In this photo illustration the stock trading graph of Johnson and Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & …
Streptococcus agalactiae bacteria, responsible for vaginal and urinary tract infections and newborn infections including meningitis and septicemia. Optical microscopy view. Cavallini James | BSIP | Universal Images Group | Getty …
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company …
Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company made both announcements as …
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Watch Morgan Stanley Hold Eli …